Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 6 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2023 Filed May 25, 2023 20:28 UTC |
Stromberg William JDirector
|
GrantCommon Stock, par value $0.01 per share | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019772 · wf-form4_168504646920736.xml · nonDerivative · entry 2 Stromberg William J · CIK 0001352578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,992 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:28 UTC |
Stromberg William JDirector
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019772 · wf-form4_168504646920736.xml · nonDerivative · entry 1 Stromberg William J · CIK 0001352578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:31 UTC |
CULP H LAWRENCE JRDirector
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019786 · wf-form4_168504665531452.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 584,543 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:30 UTC |
LESJAK CATHERINE ADirector
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019781 · wf-form4_168504657958051.xml · nonDerivative · entry 1 LESJAK CATHERINE A · CIK 0001256992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 16:29 UTC |
HOWELL LLOYD JRDirector
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019775 · wf-form4_168504651986420.xml · nonDerivative · entry 1 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:32 UTC |
Mihaljevic TomislavDirector
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019791 · wf-form4_168504672341127.xml · nonDerivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:28 UTC |
Yang Watkin Phoebe L.Director
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019774 · wf-form4_168504649835345.xml · nonDerivative · entry 1 Yang Watkin Phoebe L. · CIK 0001940538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 20:06 UTC |
Rott RolandCEO, Ultrasound
|
Tax withholdingCommon Stock, par value $0.01 per share | 837 | $82.12 | $68,734.44 |
DisclosureSEC source: 0001628280-23-010384 · wf-form4_168055239604902.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,808 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 20:06 UTC |
Zodl HelmutChief Financial Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,448 | $82.12 | $283,149.76 |
DisclosureSEC source: 0001628280-23-010383 · wf-form4_168055237917989.xml · nonDerivative · entry 1 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,009 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,037 | $0.00 Strike: $51.67 | $0.00 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · derivative · entry 10 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 4,037 shares Expires 2029-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 54,701 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · derivative · entry 9 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 54,701 shares Expires 2028-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,967 | $0.00 Strike: $57.74 | $0.00 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · derivative · entry 8 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,967 shares Expires 2029-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 240 | $0.00 Strike: $63.51 | $0.00 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · derivative · entry 7 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 240 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
SaleCommon Stock, par value $0.01 per share | 5,684 | $78.07 | $443,749.88 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 6 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,796 F2 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.95 to $78.23, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
SaleCommon Stock, par value $0.01 per share | 64,945 | $77.66 | $5,043,628.70 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 5 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,480 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.89 to $78.28, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 4,037 | $51.67 | $208,591.79 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 54,701 | $40.40 | $2,209,920.40 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 5,967 | $57.74 | $344,534.58 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:06 UTC |
Makela JanCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 240 | $63.51 | $15,242.40 |
DisclosureSEC source: 0001951803-23-000003 · wf-form4_167899717539713.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:55 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
Tax withholdingCommon Stock, par value $0.01 per share | 565 | $75.04 | $42,397.60 |
DisclosureSEC source: 0001628280-23-006437 · wf-form4_167789133085336.xml · nonDerivative · entry 3 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,557 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:55 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 437 | $75.04 | $32,792.48 |
DisclosureSEC source: 0001628280-23-006435 · wf-form4_167789128408107.xml · nonDerivative · entry 3 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,994 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:54 UTC |
Makela JanCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,525 | $75.04 | $114,436.00 |
DisclosureSEC source: 0001628280-23-006434 · wf-form4_167789125566485.xml · nonDerivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,480 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:53 UTC |
Rott RolandCEO, Ultrasound
|
Tax withholdingCommon Stock, par value $0.01 per share | 541 | $75.04 | $40,596.64 |
DisclosureSEC source: 0001628280-23-006430 · wf-form4_167789116476330.xml · nonDerivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,645 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:52 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 763 | $75.04 | $57,255.52 |
DisclosureSEC source: 0001628280-23-006427 · wf-form4_167789110493534.xml · nonDerivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,359 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 19:54 UTC |
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc.
|
GrantEmployee Stock Option (right to buy) · Derivative | 13,894 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006433 · wf-form4_167789123073387.xml · derivative · entry 2 Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,894 Underlying: Common Stock, par value $0.01 per share · 13,894 shares Expires 2033-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 19:54 UTC |
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc.
|
GrantCommon Stock, par value $0.01 per share | 4,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006433 · wf-form4_167789123073387.xml · nonDerivative · entry 1 Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,988 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC |
Jimenez Frank RGC & Corporate Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 32,419 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006431 · wf-form4_167789118758522.xml · derivative · entry 2 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,419 Underlying: Common Stock, par value $0.01 per share · 32,419 shares Expires 2033-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC |
Jimenez Frank RGC & Corporate Secretary
|
GrantCommon Stock, par value $0.01 per share | 11,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006431 · wf-form4_167789118758522.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,328 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC |
Arduini Peter JDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 109,994 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006429 · wf-form4_167789114638774.xml · derivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,994 Underlying: Common Stock, par value $0.01 per share · 109,994 shares Expires 2033-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC |
Arduini Peter JDirector · President and CEO
|
GrantCommon Stock, par value $0.01 per share | 39,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006429 · wf-form4_167789114638774.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,245 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC |
Larson Betty DChief People Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,156 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006428 · wf-form4_167789112527523.xml · derivative · entry 2 Larson Betty D · CIK 0001617903 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,156 Underlying: Common Stock, par value $0.01 per share · 23,156 shares Expires 2033-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC |
Larson Betty DChief People Officer
|
GrantCommon Stock, par value $0.01 per share | 8,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006428 · wf-form4_167789112527523.xml · nonDerivative · entry 1 Larson Betty D · CIK 0001617903 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,931 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:55 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,188 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006437 · wf-form4_167789133085336.xml · derivative · entry 4 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,188 Underlying: Common Stock, par value $0.01 per share · 10,188 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:55 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,039 | $75.30 | $78,236.70 |
DisclosureSEC source: 0001628280-23-006437 · wf-form4_167789133085336.xml · nonDerivative · entry 2 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,122 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:55 UTC |
Westrick Thomas J.CEO, Patient Care Solutions
|
GrantCommon Stock, par value $0.01 per share | 3,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006437 · wf-form4_167789133085336.xml · nonDerivative · entry 1 Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,161 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:55 UTC |
Kass-Hout TahaChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 34,271 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006436 · wf-form4_167789130903413.xml · derivative · entry 2 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,271 Underlying: Common Stock, par value $0.01 per share · 34,271 shares Expires 2033-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:55 UTC |
Kass-Hout TahaChief Technology Officer
|
GrantCommon Stock, par value $0.01 per share | 12,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006436 · wf-form4_167789130903413.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,429 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:55 UTC |
Newcomb George A.Chief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,705 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006435 · wf-form4_167789128408107.xml · derivative · entry 4 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,705 Underlying: Common Stock, par value $0.01 per share · 3,705 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:55 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 369 | $75.30 | $27,785.70 |
DisclosureSEC source: 0001628280-23-006435 · wf-form4_167789128408107.xml · nonDerivative · entry 2 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,431 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:55 UTC |
Newcomb George A.Chief Accounting Officer
|
GrantCommon Stock, par value $0.01 per share | 1,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006435 · wf-form4_167789128408107.xml · nonDerivative · entry 1 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,800 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:54 UTC |
Makela JanCEO, Imaging
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,472 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006434 · wf-form4_167789125566485.xml · derivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,472 Underlying: Common Stock, par value $0.01 per share · 25,472 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:54 UTC |
Makela JanCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,489 | $75.30 | $262,721.70 |
DisclosureSEC source: 0001628280-23-006434 · wf-form4_167789125566485.xml · nonDerivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,005 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:54 UTC |
Makela JanCEO, Imaging
|
GrantCommon Stock, par value $0.01 per share | 9,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006434 · wf-form4_167789125566485.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,494 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC |
Zodl HelmutChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,788 | $0.00 Strike: $75.30 | $0.00 |
DisclosureSEC source: 0001628280-23-006432 · wf-form4_167789121158710.xml · derivative · entry 3 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,788 Underlying: Common Stock, par value $0.01 per share · 27,788 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC |
Zodl HelmutChief Financial Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,778 | $75.30 | $133,883.40 |
DisclosureSEC source: 0001628280-23-006432 · wf-form4_167789121158710.xml · nonDerivative · entry 2 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,457 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC |
Zodl HelmutChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 9,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006432 · wf-form4_167789121158710.xml · nonDerivative · entry 1 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,235 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC |
Rott RolandCEO, Ultrasound
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,578 | $0.00 Strike: $75.30 | $0.00 |
DisclosureSEC source: 0001628280-23-006430 · wf-form4_167789116476330.xml · derivative · entry 4 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,578 Underlying: Common Stock, par value $0.01 per share · 11,578 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC |
Rott RolandCEO, Ultrasound
|
Tax withholdingCommon Stock, par value $0.01 per share | 928 | $75.30 | $69,878.40 |
DisclosureSEC source: 0001628280-23-006430 · wf-form4_167789116476330.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,186 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC |
Rott RolandCEO, Ultrasound
|
GrantCommon Stock, par value $0.01 per share | 4,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006430 · wf-form4_167789116476330.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,114 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC |
O'Neill Kevin MichaelCEO, PDx
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,188 | $0.00 Strike: $75.30 | $0.00 |
DisclosureSEC source: 0001628280-23-006427 · wf-form4_167789110493534.xml · derivative · entry 4 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,188 Underlying: Common Stock, par value $0.01 per share · 10,188 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.